Structure Therapeutics (GPCR) Total Current Liabilities (2022 - 2026)

Structure Therapeutics' Total Current Liabilities history runs 5 years deep, the most recent figure standing at $57.0 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 56.18% year-over-year to $57.0 million; the TTM figure through Mar 2026 stood at $57.0 million (up 56.18% YoY), while the FY2025 annual figure was $63.3 million, up 75.69% from the prior year.
• Total Current Liabilities was $57.0 million for Q1 2026 at Structure Therapeutics, down from $63.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $63.3 million in Q4 2025 to a low of $11.0 million in Q1 2023.
• Historically, Total Current Liabilities has averaged $32.3 million across 5 years, with a median of $29.1 million in 2023.
• Biggest YoY gain for Total Current Liabilities was 114.38% in 2024; the steepest drop was 45.6% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $13.0 million in 2022, then surged by 90.16% to $24.7 million in 2023, then jumped by 45.6% to $36.0 million in 2024, then soared by 75.69% to $63.3 million in 2025, then fell by 9.96% to $57.0 million in 2026.
• The last three Total Current Liabilities figures came in at $57.0 million (Q1 2026), $63.3 million (Q4 2025), and $57.5 million (Q3 2025), per Business Quant data.